Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America

Treatment options for the management of moderate to severe plaque psoriasis include phototherapy, oral systemic agents, and biologic therapy. Secukinumab, a fully human monoclonal antibody that selectively tar...

Source: BMC Dermatology - June 21, 2019 Category: Dermatology Authors: Kim A. Papp, Melinda Gooderham, Jennifer Beecker, Charles W. Lynde, Isabelle Delorme, Ignacio Dei-Cas, Lorne Albrecht, Emmanouil Rampakakis, John S. Sampalis, Antonio Vieira, Shamiza Hussein, Olivier Chambenoit and Lenka Rihakova Tags: Study protocol Source Type: research